Global Carotid Endarterectomy Market

Carotid Endarterectomy Comprehensive Study by Application (Hospitals, Clinics, Ambulatory Surgical Centre, Others), Diagnosis (Computed Tomography Angiography, Carotid Ultrasound, Magnetic Resonance Angiography) Players and Region - Global Market Outlook to 2028

Carotid Endarterectomy Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Carotid Endarterectomy Market?

Carotid endarterectomy is a surgical procedure performed by vascular surgeons which helps to reduce the risk of stroke by correcting in the common carotid artery or internal carotid artery. It is procedure to treat carotid artery disease. It is perform if a diagnostic test such as carotid ultrasound shows significant blockage that is likely to trigger a stroke. Carotid artery disease occurs when fatty, waxy deposits build up in one of the carotid arteries. These arteries are located on each side of the human neck.

Highlights from Carotid Endarterectomy Market Study
AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)
Key Companies ProfiledCordis Corporation (United States), Medtronic plc. (Ireland), Silk Road Medical Inc. (United States), InspireMD Inc. (Israel), Boston Scientific Corporation (United States), C.R. Bard, Inc. (United States), Cook Medical Incorporated (United States), W.L. Gore & Associates (United States), Abbott Vascular, Inc. (United States) and BIOTRONIK SE & Co. KG (Germany)


The key players are highly focusing on developing and innovating new strategies such as product launch and increased R&D to maintain their market position and customer base. The companies are also planning strategic activities like partnerships, collaboration, mergers, and acquisitions which will help them to sustain in the market and maintain their competitive edge. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Carotid Endarterectomy market throughout the forecasted period.

Cordis Corporation (United States), Medtronic plc. (Ireland), Silk Road Medical Inc. (United States), InspireMD Inc. (Israel), Boston Scientific Corporation (United States), C.R. Bard, Inc. (United States), Cook Medical Incorporated (United States), W.L. Gore & Associates (United States), Abbott Vascular, Inc. (United States) and BIOTRONIK SE & Co. KG (Germany) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Impulse Dynamics N.V. (United States).

Carotid Endarterectomy Market Segmentation:
ScopeSub-Segments
Application / End UserHospitals, Clinics, Ambulatory Surgical Centre and Others
DiagnosisComputed Tomography Angiography,Carotid Ultrasound,Magnetic Resonance Angiography


On the basis of geography, the market of Carotid Endarterectomy has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Surge In the Adoption Rates of Minimally Invasive Surgeries

Market Growth Drivers:
Increase in the Prevalence of Carotid Artery Diseases and Carotid Endarterectomy Helps To Reduce the Chance of Stroke

Challenges:
Stringent Government Rules and Regulations

Restraints:
Complications Associated With Carotid Endarterectomy

Opportunities:
Growth in the Geriatric Population and Increasing Number of Hospitals and Clinics across World

Key Target Audience
Carotid Endarterectomy Providers, Research Professionals, Emerging Companies, Government Body & Associations and End user

Market Leaders & Development Strategies
In June 2021, Boston Scientific Corporation acquired the remaining share of Farapulse. Farapulse is engaged in the development of a PFA system for treating atrial fibrillation (Afib) and other cardiac arrhythmias. The transaction to acquire Farapulse includes an upfront payment of approximately USD 295 million.
In September 2023, NAMSA, a world-leading MedTech Contract Research Organization (CRO) and InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard Embolic Prevention System (EPS) for treatment of carotid artery disease and prevention of stroke entered into a strategic outsourcing partnership to accelerate medical device development and commercialization.


Report Objectives / Segmentation Covered

By Application
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centre
  • Others
By Diagnosis
  • Computed Tomography Angiography
  • Carotid Ultrasound
  • Magnetic Resonance Angiography

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase in the Prevalence of Carotid Artery Diseases
      • 3.2.2. Carotid Endarterectomy Helps To Reduce the Chance of Stroke
    • 3.3. Market Challenges
      • 3.3.1. Stringent Government Rules and Regulations
    • 3.4. Market Trends
      • 3.4.1. Surge In the Adoption Rates of Minimally Invasive Surgeries
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Carotid Endarterectomy, by Application, Diagnosis and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Carotid Endarterectomy (Value)
      • 5.2.1. Global Carotid Endarterectomy by: Application (Value)
        • 5.2.1.1. Hospitals
        • 5.2.1.2. Clinics
        • 5.2.1.3. Ambulatory Surgical Centre
        • 5.2.1.4. Others
      • 5.2.2. Global Carotid Endarterectomy by: Diagnosis (Value)
        • 5.2.2.1. Computed Tomography Angiography
        • 5.2.2.2. Carotid Ultrasound
        • 5.2.2.3. Magnetic Resonance Angiography
      • 5.2.3. Global Carotid Endarterectomy Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Carotid Endarterectomy: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Cordis Corporation (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Medtronic plc. (Ireland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Silk Road Medical Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. InspireMD Inc. (Israel)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Boston Scientific Corporation (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. C.R. Bard, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Cook Medical Incorporated (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. W.L. Gore & Associates (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Abbott Vascular, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. BIOTRONIK SE & Co. KG (Germany)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Carotid Endarterectomy Sale, by Application, Diagnosis and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Carotid Endarterectomy (Value)
      • 7.2.1. Global Carotid Endarterectomy by: Application (Value)
        • 7.2.1.1. Hospitals
        • 7.2.1.2. Clinics
        • 7.2.1.3. Ambulatory Surgical Centre
        • 7.2.1.4. Others
      • 7.2.2. Global Carotid Endarterectomy by: Diagnosis (Value)
        • 7.2.2.1. Computed Tomography Angiography
        • 7.2.2.2. Carotid Ultrasound
        • 7.2.2.3. Magnetic Resonance Angiography
      • 7.2.3. Global Carotid Endarterectomy Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Carotid Endarterectomy: by Application(USD Million)
  • Table 2. Carotid Endarterectomy Hospitals , by Region USD Million (2017-2022)
  • Table 3. Carotid Endarterectomy Clinics , by Region USD Million (2017-2022)
  • Table 4. Carotid Endarterectomy Ambulatory Surgical Centre , by Region USD Million (2017-2022)
  • Table 5. Carotid Endarterectomy Others , by Region USD Million (2017-2022)
  • Table 6. Carotid Endarterectomy: by Diagnosis(USD Million)
  • Table 7. Carotid Endarterectomy Computed Tomography Angiography , by Region USD Million (2017-2022)
  • Table 8. Carotid Endarterectomy Carotid Ultrasound , by Region USD Million (2017-2022)
  • Table 9. Carotid Endarterectomy Magnetic Resonance Angiography , by Region USD Million (2017-2022)
  • Table 10. South America Carotid Endarterectomy, by Country USD Million (2017-2022)
  • Table 11. South America Carotid Endarterectomy, by Application USD Million (2017-2022)
  • Table 12. South America Carotid Endarterectomy, by Diagnosis USD Million (2017-2022)
  • Table 13. Brazil Carotid Endarterectomy, by Application USD Million (2017-2022)
  • Table 14. Brazil Carotid Endarterectomy, by Diagnosis USD Million (2017-2022)
  • Table 15. Argentina Carotid Endarterectomy, by Application USD Million (2017-2022)
  • Table 16. Argentina Carotid Endarterectomy, by Diagnosis USD Million (2017-2022)
  • Table 17. Rest of South America Carotid Endarterectomy, by Application USD Million (2017-2022)
  • Table 18. Rest of South America Carotid Endarterectomy, by Diagnosis USD Million (2017-2022)
  • Table 19. Asia Pacific Carotid Endarterectomy, by Country USD Million (2017-2022)
  • Table 20. Asia Pacific Carotid Endarterectomy, by Application USD Million (2017-2022)
  • Table 21. Asia Pacific Carotid Endarterectomy, by Diagnosis USD Million (2017-2022)
  • Table 22. China Carotid Endarterectomy, by Application USD Million (2017-2022)
  • Table 23. China Carotid Endarterectomy, by Diagnosis USD Million (2017-2022)
  • Table 24. Japan Carotid Endarterectomy, by Application USD Million (2017-2022)
  • Table 25. Japan Carotid Endarterectomy, by Diagnosis USD Million (2017-2022)
  • Table 26. India Carotid Endarterectomy, by Application USD Million (2017-2022)
  • Table 27. India Carotid Endarterectomy, by Diagnosis USD Million (2017-2022)
  • Table 28. South Korea Carotid Endarterectomy, by Application USD Million (2017-2022)
  • Table 29. South Korea Carotid Endarterectomy, by Diagnosis USD Million (2017-2022)
  • Table 30. Taiwan Carotid Endarterectomy, by Application USD Million (2017-2022)
  • Table 31. Taiwan Carotid Endarterectomy, by Diagnosis USD Million (2017-2022)
  • Table 32. Australia Carotid Endarterectomy, by Application USD Million (2017-2022)
  • Table 33. Australia Carotid Endarterectomy, by Diagnosis USD Million (2017-2022)
  • Table 34. Rest of Asia-Pacific Carotid Endarterectomy, by Application USD Million (2017-2022)
  • Table 35. Rest of Asia-Pacific Carotid Endarterectomy, by Diagnosis USD Million (2017-2022)
  • Table 36. Europe Carotid Endarterectomy, by Country USD Million (2017-2022)
  • Table 37. Europe Carotid Endarterectomy, by Application USD Million (2017-2022)
  • Table 38. Europe Carotid Endarterectomy, by Diagnosis USD Million (2017-2022)
  • Table 39. Germany Carotid Endarterectomy, by Application USD Million (2017-2022)
  • Table 40. Germany Carotid Endarterectomy, by Diagnosis USD Million (2017-2022)
  • Table 41. France Carotid Endarterectomy, by Application USD Million (2017-2022)
  • Table 42. France Carotid Endarterectomy, by Diagnosis USD Million (2017-2022)
  • Table 43. Italy Carotid Endarterectomy, by Application USD Million (2017-2022)
  • Table 44. Italy Carotid Endarterectomy, by Diagnosis USD Million (2017-2022)
  • Table 45. United Kingdom Carotid Endarterectomy, by Application USD Million (2017-2022)
  • Table 46. United Kingdom Carotid Endarterectomy, by Diagnosis USD Million (2017-2022)
  • Table 47. Netherlands Carotid Endarterectomy, by Application USD Million (2017-2022)
  • Table 48. Netherlands Carotid Endarterectomy, by Diagnosis USD Million (2017-2022)
  • Table 49. Rest of Europe Carotid Endarterectomy, by Application USD Million (2017-2022)
  • Table 50. Rest of Europe Carotid Endarterectomy, by Diagnosis USD Million (2017-2022)
  • Table 51. MEA Carotid Endarterectomy, by Country USD Million (2017-2022)
  • Table 52. MEA Carotid Endarterectomy, by Application USD Million (2017-2022)
  • Table 53. MEA Carotid Endarterectomy, by Diagnosis USD Million (2017-2022)
  • Table 54. Middle East Carotid Endarterectomy, by Application USD Million (2017-2022)
  • Table 55. Middle East Carotid Endarterectomy, by Diagnosis USD Million (2017-2022)
  • Table 56. Africa Carotid Endarterectomy, by Application USD Million (2017-2022)
  • Table 57. Africa Carotid Endarterectomy, by Diagnosis USD Million (2017-2022)
  • Table 58. North America Carotid Endarterectomy, by Country USD Million (2017-2022)
  • Table 59. North America Carotid Endarterectomy, by Application USD Million (2017-2022)
  • Table 60. North America Carotid Endarterectomy, by Diagnosis USD Million (2017-2022)
  • Table 61. United States Carotid Endarterectomy, by Application USD Million (2017-2022)
  • Table 62. United States Carotid Endarterectomy, by Diagnosis USD Million (2017-2022)
  • Table 63. Canada Carotid Endarterectomy, by Application USD Million (2017-2022)
  • Table 64. Canada Carotid Endarterectomy, by Diagnosis USD Million (2017-2022)
  • Table 65. Mexico Carotid Endarterectomy, by Application USD Million (2017-2022)
  • Table 66. Mexico Carotid Endarterectomy, by Diagnosis USD Million (2017-2022)
  • Table 67. Company Basic Information, Sales Area and Its Competitors
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Carotid Endarterectomy: by Application(USD Million)
  • Table 78. Carotid Endarterectomy Hospitals , by Region USD Million (2023-2028)
  • Table 79. Carotid Endarterectomy Clinics , by Region USD Million (2023-2028)
  • Table 80. Carotid Endarterectomy Ambulatory Surgical Centre , by Region USD Million (2023-2028)
  • Table 81. Carotid Endarterectomy Others , by Region USD Million (2023-2028)
  • Table 82. Carotid Endarterectomy: by Diagnosis(USD Million)
  • Table 83. Carotid Endarterectomy Computed Tomography Angiography , by Region USD Million (2023-2028)
  • Table 84. Carotid Endarterectomy Carotid Ultrasound , by Region USD Million (2023-2028)
  • Table 85. Carotid Endarterectomy Magnetic Resonance Angiography , by Region USD Million (2023-2028)
  • Table 86. South America Carotid Endarterectomy, by Country USD Million (2023-2028)
  • Table 87. South America Carotid Endarterectomy, by Application USD Million (2023-2028)
  • Table 88. South America Carotid Endarterectomy, by Diagnosis USD Million (2023-2028)
  • Table 89. Brazil Carotid Endarterectomy, by Application USD Million (2023-2028)
  • Table 90. Brazil Carotid Endarterectomy, by Diagnosis USD Million (2023-2028)
  • Table 91. Argentina Carotid Endarterectomy, by Application USD Million (2023-2028)
  • Table 92. Argentina Carotid Endarterectomy, by Diagnosis USD Million (2023-2028)
  • Table 93. Rest of South America Carotid Endarterectomy, by Application USD Million (2023-2028)
  • Table 94. Rest of South America Carotid Endarterectomy, by Diagnosis USD Million (2023-2028)
  • Table 95. Asia Pacific Carotid Endarterectomy, by Country USD Million (2023-2028)
  • Table 96. Asia Pacific Carotid Endarterectomy, by Application USD Million (2023-2028)
  • Table 97. Asia Pacific Carotid Endarterectomy, by Diagnosis USD Million (2023-2028)
  • Table 98. China Carotid Endarterectomy, by Application USD Million (2023-2028)
  • Table 99. China Carotid Endarterectomy, by Diagnosis USD Million (2023-2028)
  • Table 100. Japan Carotid Endarterectomy, by Application USD Million (2023-2028)
  • Table 101. Japan Carotid Endarterectomy, by Diagnosis USD Million (2023-2028)
  • Table 102. India Carotid Endarterectomy, by Application USD Million (2023-2028)
  • Table 103. India Carotid Endarterectomy, by Diagnosis USD Million (2023-2028)
  • Table 104. South Korea Carotid Endarterectomy, by Application USD Million (2023-2028)
  • Table 105. South Korea Carotid Endarterectomy, by Diagnosis USD Million (2023-2028)
  • Table 106. Taiwan Carotid Endarterectomy, by Application USD Million (2023-2028)
  • Table 107. Taiwan Carotid Endarterectomy, by Diagnosis USD Million (2023-2028)
  • Table 108. Australia Carotid Endarterectomy, by Application USD Million (2023-2028)
  • Table 109. Australia Carotid Endarterectomy, by Diagnosis USD Million (2023-2028)
  • Table 110. Rest of Asia-Pacific Carotid Endarterectomy, by Application USD Million (2023-2028)
  • Table 111. Rest of Asia-Pacific Carotid Endarterectomy, by Diagnosis USD Million (2023-2028)
  • Table 112. Europe Carotid Endarterectomy, by Country USD Million (2023-2028)
  • Table 113. Europe Carotid Endarterectomy, by Application USD Million (2023-2028)
  • Table 114. Europe Carotid Endarterectomy, by Diagnosis USD Million (2023-2028)
  • Table 115. Germany Carotid Endarterectomy, by Application USD Million (2023-2028)
  • Table 116. Germany Carotid Endarterectomy, by Diagnosis USD Million (2023-2028)
  • Table 117. France Carotid Endarterectomy, by Application USD Million (2023-2028)
  • Table 118. France Carotid Endarterectomy, by Diagnosis USD Million (2023-2028)
  • Table 119. Italy Carotid Endarterectomy, by Application USD Million (2023-2028)
  • Table 120. Italy Carotid Endarterectomy, by Diagnosis USD Million (2023-2028)
  • Table 121. United Kingdom Carotid Endarterectomy, by Application USD Million (2023-2028)
  • Table 122. United Kingdom Carotid Endarterectomy, by Diagnosis USD Million (2023-2028)
  • Table 123. Netherlands Carotid Endarterectomy, by Application USD Million (2023-2028)
  • Table 124. Netherlands Carotid Endarterectomy, by Diagnosis USD Million (2023-2028)
  • Table 125. Rest of Europe Carotid Endarterectomy, by Application USD Million (2023-2028)
  • Table 126. Rest of Europe Carotid Endarterectomy, by Diagnosis USD Million (2023-2028)
  • Table 127. MEA Carotid Endarterectomy, by Country USD Million (2023-2028)
  • Table 128. MEA Carotid Endarterectomy, by Application USD Million (2023-2028)
  • Table 129. MEA Carotid Endarterectomy, by Diagnosis USD Million (2023-2028)
  • Table 130. Middle East Carotid Endarterectomy, by Application USD Million (2023-2028)
  • Table 131. Middle East Carotid Endarterectomy, by Diagnosis USD Million (2023-2028)
  • Table 132. Africa Carotid Endarterectomy, by Application USD Million (2023-2028)
  • Table 133. Africa Carotid Endarterectomy, by Diagnosis USD Million (2023-2028)
  • Table 134. North America Carotid Endarterectomy, by Country USD Million (2023-2028)
  • Table 135. North America Carotid Endarterectomy, by Application USD Million (2023-2028)
  • Table 136. North America Carotid Endarterectomy, by Diagnosis USD Million (2023-2028)
  • Table 137. United States Carotid Endarterectomy, by Application USD Million (2023-2028)
  • Table 138. United States Carotid Endarterectomy, by Diagnosis USD Million (2023-2028)
  • Table 139. Canada Carotid Endarterectomy, by Application USD Million (2023-2028)
  • Table 140. Canada Carotid Endarterectomy, by Diagnosis USD Million (2023-2028)
  • Table 141. Mexico Carotid Endarterectomy, by Application USD Million (2023-2028)
  • Table 142. Mexico Carotid Endarterectomy, by Diagnosis USD Million (2023-2028)
  • Table 143. Research Programs/Design for This Report
  • Table 144. Key Data Information from Secondary Sources
  • Table 145. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Carotid Endarterectomy: by Application USD Million (2017-2022)
  • Figure 5. Global Carotid Endarterectomy: by Diagnosis USD Million (2017-2022)
  • Figure 6. South America Carotid Endarterectomy Share (%), by Country
  • Figure 7. Asia Pacific Carotid Endarterectomy Share (%), by Country
  • Figure 8. Europe Carotid Endarterectomy Share (%), by Country
  • Figure 9. MEA Carotid Endarterectomy Share (%), by Country
  • Figure 10. North America Carotid Endarterectomy Share (%), by Country
  • Figure 11. Global Carotid Endarterectomy share by Players 2022 (%)
  • Figure 12. Global Carotid Endarterectomy share by Players (Top 3) 2022(%)
  • Figure 13. Global Carotid Endarterectomy share by Players (Top 5) 2022(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Cordis Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 16. Cordis Corporation (United States) Revenue: by Geography 2022
  • Figure 17. Medtronic plc. (Ireland) Revenue, Net Income and Gross profit
  • Figure 18. Medtronic plc. (Ireland) Revenue: by Geography 2022
  • Figure 19. Silk Road Medical Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 20. Silk Road Medical Inc. (United States) Revenue: by Geography 2022
  • Figure 21. InspireMD Inc. (Israel) Revenue, Net Income and Gross profit
  • Figure 22. InspireMD Inc. (Israel) Revenue: by Geography 2022
  • Figure 23. Boston Scientific Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 24. Boston Scientific Corporation (United States) Revenue: by Geography 2022
  • Figure 25. C.R. Bard, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. C.R. Bard, Inc. (United States) Revenue: by Geography 2022
  • Figure 27. Cook Medical Incorporated (United States) Revenue, Net Income and Gross profit
  • Figure 28. Cook Medical Incorporated (United States) Revenue: by Geography 2022
  • Figure 29. W.L. Gore & Associates (United States) Revenue, Net Income and Gross profit
  • Figure 30. W.L. Gore & Associates (United States) Revenue: by Geography 2022
  • Figure 31. Abbott Vascular, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. Abbott Vascular, Inc. (United States) Revenue: by Geography 2022
  • Figure 33. BIOTRONIK SE & Co. KG (Germany) Revenue, Net Income and Gross profit
  • Figure 34. BIOTRONIK SE & Co. KG (Germany) Revenue: by Geography 2022
  • Figure 35. Global Carotid Endarterectomy: by Application USD Million (2023-2028)
  • Figure 36. Global Carotid Endarterectomy: by Diagnosis USD Million (2023-2028)
  • Figure 37. South America Carotid Endarterectomy Share (%), by Country
  • Figure 38. Asia Pacific Carotid Endarterectomy Share (%), by Country
  • Figure 39. Europe Carotid Endarterectomy Share (%), by Country
  • Figure 40. MEA Carotid Endarterectomy Share (%), by Country
  • Figure 41. North America Carotid Endarterectomy Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Cordis Corporation (United States)
  • Medtronic plc. (Ireland)
  • Silk Road Medical Inc. (United States)
  • InspireMD Inc. (Israel)
  • Boston Scientific Corporation (United States)
  • C.R. Bard, Inc. (United States)
  • Cook Medical Incorporated (United States)
  • W.L. Gore & Associates (United States)
  • Abbott Vascular, Inc. (United States)
  • BIOTRONIK SE & Co. KG (Germany)
Additional players considered in the study are as follows:
Impulse Dynamics N.V. (United States)
Select User Access Type

Key Highlights of Report


May 2023 238 Pages 71 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Carotid Endarterectomy Market Quantitative research analysis
Global Carotid Endarterectomy Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

"Increase in the Prevalence of Carotid Artery Diseases " is seen as one of major growth factors of Carotid Endarterectomy Market in years to come.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
The Carotid Endarterectomy market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete of companies available in our research coverage.

Know More About Global Carotid Endarterectomy Market Report?

Have a Query? Click Here

Other Related Reports

Wilson's Disease Treatment Comprehensive Study by Type (Medication (Trientine, Penicillamine, Zinc Acatate), Surgery), Application (Hospitals, Specialty Clinics, Diagnostic Laboratories), Test Type (...
$ 3750
Myelodysplastic Syndrome Comprehensive Study by Type (Alkylating Agents, Cytotoxic Antibiotics, Topoisomerase Inhibitors, Others), Application (Hospital, Clinic), Route of Administration (Generic, Or...
$ 3650
Vertebral Compression Fracture Devices Comprehensive Study by Type (Balloon Kyphoplasty Devices, Vertebroplasty Devices), Surgery Type (Open Spine Surgery, Minimally Invasive Spine Surgery, Lumbar Fu...
$ 3650
Chronic Obstructive Pulmonary Disease Comprehensive Study by Disease Type (Emphysema, Chronic Bronchitis), Age Group (Children, Adults), Treatment Type (Medication, Oxygen Therapy, Pulmonary Rehabili...
$ 3800
T-Cell Immunotherapy Comprehensive Study by Type (Active Immunotherapy, Passive Immunotherapy), Application (Stomach Cancer, Lung Cancer, Colorectal Cancer, Esophagus Cancer, Pancreatic Cancer, Other...
$ 3750
Malaria Diagnostics Comprehensive Study by Type (Microscopy, Rapid Diagnostic Tests, Molecular Diagnostic Tests (Conventional PCR, Real-Time PCR (quantitative PCR or qPCR))), End User (Clinics, Hospi...
$ 3350